StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by Bungeon Jan 25, 2021 8:49am

176 Views

Post# 32373634

L2

Level 2 Quote

Level two quotes - Bid
Number of Shares		Bid Price
116,500 shares	116,500	1.200
8,800 shares	8,800	1.190
22,700 shares	22,700	1.180
4,000 shares	4,000	1.170
4,500 shares	4,500	1.160
15,900 shares	15,900	1.150
62,100 shares	62,100	1.140
13,300 shares	13,300	1.130
1,700 shares	1,700	1.120
4,000 shares	4,000	1.100

Level two quotes - Ask
Ask Price	Number of Shares
1.200	116,800	116,800 shares
1.240	2,000	2,000 shares
1.250	43,500	43,500 shares
1.260	1,500	1,500 shares
1.270	25,000	25,000 shares
1.280	4,700	4,700 shares
1.300	10,100	10,100 shares
1.310	5,000	5,000 shares
1.320	17,800	17,800 shares
1.350	16,500